The FDA has appointed one of its most respected cancer drug regulators to lead the agency’s main division for approving new drugs.

The FDA has cleared BrainsWay’s Deep Transcranial Magnetic Stimulation system for use as an adjunct therapy in adolescents with major depressive disorder.

Representation of minority groups among neurology residency applicants grew from 2007 to 2020, but matriculants remain underrepresented.

One-third of congenital cytomegalovirus-related hearing loss would be missed without universal screening programs.

Overall rates of nicotine vaping declined among US youth, but those who continue to vape are showing signs of worsening addiction.

The Trump administration directed visa officers to consider chronic health conditions when deciding whether to approve entry into the US.

Lewy body dementia is often misdiagnosed as Alzheimer disease, despite high specificity of clinical diagnosis.

Findings showed fenebrutinib significantly reduced relapses vs teriflunomide in RMS and was noninferior to ocrelizumab in slowing disability progression in PPMS. Topline data were announced from two ...